Hangzhou Shangjian Biotechnology Co., Ltd.
PrivateLast Round
Series B
Extension
Dec 30, 2021
Total Funding Raised
$32.34M
Company Overview
Hangzhou Shangjian Biotechnology Co., Ltd. is a biopharmaceutical company focused on the research and development of novel antibody therapeutics, including monoclonal antibodies, bispecific antibodies, and antibody-drug conjugates.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou Shangjian Biotechnology Co., Ltd. Comparables
Compare Hangzhou Shangjian Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TJ Biopharma | 87% | |
| CASI Pharmaceuticals | 79% | |
| Johnson & Johnson | 73% | |
Hangzhou Shangjian Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Dec 30, 2021 | ||||
| Series B | Sep 15, 2020 | ||||
| Series A Extension | Jan 1, 2019 | ||||
| Series A | Jun 1, 2018 | ||||
| Angel | Mar 1, 2017 |
Hangzhou Shangjian Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zheshang Venture Capital | Series B Extension |
| Zhejiang Sino Wisdom Investment Management | Series B |
| BOCOM International Holdings Company Limited | Series B |
| Addor Capital | Series B Extension, Series B |
| Hankang Capital | Series B Extension, Series A |
| Cowin Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 15, 2020
$32M round led by Addor Capital, Cowin Capital, and Zhejiang Sino Wisdom.
- Jun 1, 2018
Hankang Capital led the Series A round.
Hangzhou Shangjian Biotechnology Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hangzhou Shangjian Biotechnology Co., Ltd.'s valuation, stock price, and market status.